Evidence for the presence of type I IL-1 receptors on beta-cells of islets of Langerhans (Q41074875)

26 September 2017

title

Evidence for the presence of type I IL-1 receptors on beta-cells of islets of Langerhans (English)

1 reference

26 September 2017

A L Scarim

1

1 reference

26 September 2017

M Arnush

2

1 reference

26 September 2017

J R Hill

3

1 reference

26 September 2017

C A Marshall

4

1 reference

26 September 2017

A Baldwin

5

1 reference

26 September 2017

M L McDaniel

6

1 reference

26 September 2017

J A Corbett

7

1 reference

26 September 2017

publication date

1 October 1997

1 reference

Biochimica et Biophysica Acta

26 September 2017

published in

1 reference

26 September 2017

volume

1361

1 reference

26 September 2017

issue

3

1 reference

26 September 2017

page(s)

313-320

1 reference

Cytokines cause functional and structural damage to isolated islets of Langerhans

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Interaction of beta-cell activity and IL-1 concentration and exposure time in isolated rat islets of Langerhans.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Interleukin 1 is potent modulator of insulin secretion from isolated rat islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Insulin-secreting beta-cells possess specific receptors for interleukin-1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Tyrosine kinase involvement in IL-1 beta-induced expression of iNOS by beta-cells purified from islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Nitric oxide as a secretory product of mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Interleukin-lβ-Induced Nitric Oxide Production in Isolated Rat Pancreatic Islets Requires Gene Transcription and May Lead to Inhibition of the Krebs Cycle Enzyme Aconitase*

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Nitric oxide and cyclic GMP formation induced by interleukin 1 beta in islets of Langerhans. Evidence for an effector role of nitric oxide in islet dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Role of receptor binding and gene transcription for both the stimulatory and inhibitory effects of interleukin-1 in pancreatic beta-cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

An interleukin-1 receptor antagonist protein protects insulin-producing Beta cells against suppressive effects of interleukin-1?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Preparation of single cells from pancreatic islets of adult rat by the use of dispase

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

A new in vitro model for the study of pancreatic A and B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Insulin immunoassay by back-titration; some characteristics of the technic and the insulin precipitant action of alcohol.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Selective inhibition of the inducible nitric oxide synthase by aminoguanidine

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Interleukin 1 participates in the development of anti-Listeria responses in normal and SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Interleukin 1 signaling occurs exclusively via the type I receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Identification and distribution of two forms of the interleukin 1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

Interleukin‐1 ‐induced expression of nitric oxide synthase in insulin‐producing cells is preceded by c‐fos induction and depends on gene transcription and protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2897%2900039-2

7 January 2021

10.1016/S0925-4439(97)00039-2

Identifiers

DOI

1 reference

26 September 2017

1 reference